Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical Trials
- 1 October 1996
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 795 (1) , 440-454
- https://doi.org/10.1111/j.1749-6632.1996.tb52715.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Successful Culture and Selection of Cytokine Gene-Modified Human Dermal Fibroblasts for the Biologic Therapy of Patients with CancerHuman Gene Therapy, 1996
- IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts. University of Pittsburgh, Pittsburgh, PennsylvaniaHuman Gene Therapy, 1995
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Diet and gastric cancer. A case‐control study in BelgiumInternational Journal of Cancer, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.The Journal of Experimental Medicine, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.The Journal of Experimental Medicine, 1989
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989